Descriptive statistics for DAPSA on weeks 12 and 24
| Treatment group | n | Baseline mean (SD) | Time-point mean (SD) | Change* in mean (SD) | Change* in p value | Between-treatment p value† |
|---|---|---|---|---|---|---|
| Week 12 | ||||||
| ETN 50 mg twice weekly/50 mg once weekly | 323 | 42.41 (29.10) | 17.16 (22.01) | −25.3 (22.18) | <0.0001 | 0.7378 |
| ETN 50 mg once weekly/50 mg once weekly | 319 | 42.62 (29.03) | 17.81 (20.73) | −24.8 (25.23) | <0.0001 | |
| Week 24 | ||||||
| ETN 50 mg twice weekly/50 mg once weekly | 329 | 42.34 (28.90) | 14.55 (21.01) | −27.8 (25.27) | <0.0001 | 0.3414 |
| ETN 50 mg once weekly/50 mg once weekly | 324 | 42.80 (29.28) | 13.47 (18.03) | −29.3 (26.32) | <0.0001 | |